GORI, ANDREA

GORI, ANDREA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 155 (tempo di esecuzione: 0.073 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 02 - Intervento a convegno 2023 Lisa PaganiPaolo PrevitaliClizia ChinelloGiulia CapitoliGiulia RiscaRenato Alberto SinicoBarbara TrezziAndrea LombardiAndrea GoriAlessandra BanderaCristina MeregalliGuido CavalettiFulvio Magni +
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 01 - Articolo su rivista 2023 Bernasconi D.Squillace N.Muscatello A.Bandera A.Gori A. +
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 01 - Articolo su rivista 2023 Pagani, LisaChinello, CliziaRisca, GiuliaCapitoli, GiuliaCriscuolo, LucreziaPiga, IsabellaMuscatello, AntonioFavalli, AndreaGori, AndreaBandera, AlessandraMagni, Fulvio +
Characterization of SARS-CoV-2 proteins and human proteome in COVID-19 patients’ saliva and plasma: an untargeted mass spectrometry approach 02 - Intervento a convegno 2022 Pagani, LChinello, CMahajneh, AClerici, FPanarello, GFavalli, ABandera, AMuscatello, AGori, AMagni, F +
Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study(Front. Med., (2022), 9, (850858), 10.3389/fmed.2022.850858) 99 - Altro 2022 Gobbini A.Favalli A.Bandera A.Gori A. +
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 01 - Articolo su rivista 2022 Favalli A.Gobbini A.Marongiu L.Granucci F.Bandera A.Gori A. +
Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy 01 - Articolo su rivista 2022 Corrao G.Franchi M.Leoni O.Gori A. +
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 02 - Intervento a convegno 2022 Pagani, LChinello, CMahajneh, AClerici, FCriscuolo, LCapitoli, GRisca, GFavalli, ABandera, ALombardi, AMuscatello, AGori, AMagni, F +
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 01 - Articolo su rivista 2022 Colombo M.Marongiu L.Mingozzi F.Marzi R.Cigni C.Facchini F. A.Rotem R.Valache M.Stucchi G.Rocca G.Gornati L.Rizzuto M. A.Salvioni L.Zanoni I.Gori A.Prosperi D.Granucci F.
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 01 - Articolo su rivista 2022 Pagani, LisaChinello, CliziaClerici, FrancescaFavalli, AndreaMuscatello, AntonioGori, AndreaMagni, Fulvio +
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 01 - Articolo su rivista 2021 Soria A.Fagiuoli S.Bruno R.Gori A.Puoti M.Bonfanti P. +
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 01 - Articolo su rivista 2021 Puoti M.Bandera A.Bonfanti P.Gori A.Lapadula G. +
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 02 - Intervento a convegno 2021 Lisa PaganiClizia ChinelloAllia MahajnehFrancesca ClericiGaia PanarelloAndrea FavalliAlessandra BanderaAntonio MuscatelloAndrea GoriFulvio Magni +
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 01 - Articolo su rivista 2020 Gori A.Puoti M.Bandera A.Lapadula G.Bonfanti P. +
Combination antifungal therapy for invasive mold infections among pediatric patients with hematological malignancies: Data from a real-life case-series 01 - Articolo su rivista 2019 Longhi B.Migliorino G. M.Bandera A.Rizzari C.Gori A.Colombini A. +
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 01 - Articolo su rivista 2019 Gori A.Migliorino G.Puoti M. +
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 01 - Articolo su rivista 2019 Puoti M.Bandera A.Bonfanti P.Gori A.Lapadula G. +
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 01 - Articolo su rivista 2019 Puoti M.Gori A.Soria A.Strazzabosco M.Ciaccio A.Gemma M.Foti G. +
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 01 - Articolo su rivista 2019 Puoti M.Bonfanti P.Gori A.Lapadula G. +
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort Study 01 - Articolo su rivista 2019 Puoti M.Gori A. +